Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced ...

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...